[ad_1]
May 20, 2021, Raritan, New Jersey (GLOBE NEWSWIRE)-Ortho Clinical Diagnostics (NASDAQ:OCDX) Is one of the world’s largest in vitro diagnostic (IVD) companies. The company announced today that members of its management team plan to deliver speeches at two upcoming investor conferences:
- Monday, May 24, 2021, US Eastern Time, UBS Virtual Global Healthcare Conference
- Goldman Sachs 42nd Wednesday, June 9, 2021, the Annual Global Healthcare Conference Eastern Time
Interested parties can access the real-time webcast and replay each presentation in the “Investors” section of the company website at: https://ir.orthoclinicaldiagnostics.com/, Under the “Events” section. The management will also hold separate meetings with investors at two meetings.
About clinical diagnosis
Ortho Clinical Diagnostics (NASDAQ:OCDX) Is one of the world’s largest in vitro diagnostic (IVD) companies.
Every day, more than 800,000 patients worldwide are affected by the Ortho test. Because every test is life™, Ortho provides innovative technologies and tools for hospitals, hospital networks, clinical laboratories and blood banks around the world to ensure rapid, accurate and reliable test results. Ortho’s customized solutions can improve clinical results, improve efficiency, overcome laboratory staffing challenges and reduce costs.
From the release of the first product that can determine the Rh+ or Rh- blood type to the development of the world’s first test to detect antibodies against HIV and hepatitis C, the patented dry slide technology was introduced and the first US food and High-volume products authorized by the Drug Administration For more than 80 years, Ortho has been a pioneer in the field of IVD, conducting antibody and antigen testing for COVID-19.
The company is supported by Ortho Care™, an award-winning overall service and support program that ensures first-class technology, on-site and remote service, and inventory support for laboratories in more than 130 countries and regions around the world .
For more information, please visit Ortho’s website Or social media channels: LinkedIn, Twitter, Facebook with YouTube.
Investors:
IR@orthoclinicaldiagnostics.com
media:
media@orthoclinicaldiagnostics.com
[ad_2]
Source link
